Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Enzolytics Inc
(OP:
ENZC
)
0.0106
+0.0005 (+4.95%)
Streaming Delayed Price
Updated: 3:51 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,223,216
Open
0.0100
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0101
Today's Range
0.0090 - 0.0120
52wk Range
0.0077 - 0.1320
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Stocks Under 5¢ To Watch Now! HNRC, HALB, ENZC, SNNC, SPZI
February 29, 2024
Via
AB Newswire
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Economy
OTC Stocks to Watch in February: CLNV, HNRC, ENZC, GEVI, PBIO
February 06, 2024
Via
AB Newswire
Topics
Artificial Intelligence
Bonds
Exposures
Artificial Intelligence
Debt Markets
Performance
YTD
-45.36%
-45.36%
1 Month
-38.73%
-38.73%
3 Month
-28.38%
-28.38%
6 Month
-73.50%
-73.50%
1 Year
-76.86%
-76.86%
More News
Read More
“Exploring Market Opportunities Stocks to Watch Under 5¢ Now: CLNV, ENZC, HNRC, HALB, SPZI”
January 25, 2024
Via
AB Newswire
Topics
Artificial Intelligence
Energy
Exposures
Artificial Intelligence
Fossil Fuels
Enzolytics, Inc. Announces Partnership With the Khalpey AI Lab To Forge the Future of Multi-Organ Remodeling and Rejuvenation With a Strategic Focus on Longevity
January 16, 2024
Via
ACCESSWIRE
Penny Stocks, Shifts in Trends, Notable Performances, and Strategic Developments, Opportunities: CLNV, HALB, SPZI, HNRC, ENZC
January 09, 2024
Via
AB Newswire
Topics
Bonds
Economy
Exposures
Debt Markets
Economy
Enzolytics Announces the Signing of the Business Combination Agreement with Sagaliam Acquisition Corp (SAGA)
September 18, 2023
Via
ACCESSWIRE
Patient Population for the Clinical Trials of ITV-1 has been Established by the European Medicines Agency ("EMA")
September 06, 2023
Via
ACCESSWIRE
Enzolytics, Inc. Files Amended December 31, 2022 OTC Report with Audited Financials and Unaudited September 30, 2023 Quarterly Disclosure
November 20, 2023
Via
ACCESSWIRE
Biogenysis, Inc. Announces Partnering with Khalpey AI Lab and Contenta, Ltd. to Incorporate AI in Microbiome Analysis to Identify Biomarkers for Use in Accurately Predicting Alzheimer's Disease Onset and Prevention.
September 05, 2023
Via
ACCESSWIRE
Biogenysis’ International Patent Application, Covering Its Anti-SARS-CoV-2 Monoclonal Antibodies, Advances to Prosecution in Europe and as a U.S. National Stage Application.
August 24, 2023
Via
ACCESSWIRE
Virogentics, Inc. Receives Permit for Export to Africa of the ITV-1 Immunotherapy Solidifying the Scheduled Administration of the Treatment
August 08, 2023
Via
ACCESSWIRE
Virogentics, Inc. Provides Update on African Project, European Medicine Agency Application and Clinical Trials for Application for Type 2 Diabetes
August 04, 2023
Via
ACCESSWIRE
CORRECTION FROM SOURCE: Virogentics Announces Approval of Final Protocol from the Dept for HIV and AIDS, Ministry of Health of the DRC
July 24, 2023
Via
ACCESSWIRE
Virogentics, Inc to Introduce a Dietary Supplement Offers Additional Information on ITV-1 and Diabetic Clinical Trials
July 24, 2023
Via
ACCESSWIRE
Exploring Breakthrough Biotech Stocks: ENZC, CYDY, HGEN, HALB
July 19, 2023
Via
AB Newswire
Enzolytics Inc. Files Supplemental Information Report on the Sale of Biogenysis, Inc. and Virogentics, Inc to Sagaliam Acquisition Corp.
July 11, 2023
Via
ACCESSWIRE
Biogenysis Inc. Announces a Collaboration with Khalpey AI Lab in using Artificial Intelligence (AI) for Unveiling Potential Biomarkers and Predicting the Onset or Prevention of Alzheimer's Disease.
July 21, 2023
Via
ACCESSWIRE
Virogentics, Inc to Introduce a Dietary Supplement Offers Additional Information on ITV-1 And Diabetic Clinical Trials
July 06, 2023
Via
ACCESSWIRE
Enzolytics, Inc. Reports Amendment to Non-Binding Term Sheet with the Special Purpose Acquisition Company Sagaliam Acquisition Corp.
June 29, 2023
Via
ACCESSWIRE
Enzolytics Offers Update on Virogentics, Inc ITV-1 African Project
June 26, 2023
Via
ACCESSWIRE
Stock Market Surges “Milestones Reached”: SWISF / SKUR.C, NWBO, ENZC, ABML
June 12, 2023
Via
AB Newswire
Enzolytics Offers Update on Virogentics and Sale Transaction, Clinical Trials Progress on European Medicine Agency (EMA) Permitting and Arican ITV-1 Project
June 05, 2023
Via
ACCESSWIRE
Virogentics and Enzolytics Refute Misleading Information Being Circulated on Social Media and Other Internet Outlets Biogenesis to be Featured in June Issue of Life Science Review
May 19, 2023
Via
ACCESSWIRE
Virogentics Inc. Receives Report from Bulgarian Academy of Sciences Administration of ITV-1 to Begin First Week in June 2023
May 16, 2023
Via
ACCESSWIRE
Undervalued Biotech Stocks to Watch After Enzolytics’ (OTC:ENZC) 300% Run: RMED, SPPI, HALB, VXRT
May 12, 2023
Via
AB Newswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.